Stelios Papadopoulos - Director at Regulus Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
RGLS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stelios Papadopoulos since 12/22/2023

Holdings reported by Stelios Papadopoulos for Regulus Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 978K $1.57M $1.60 Mar 14, 2024 Direct
Stock Option (Right to Buy) 60K May 20, 2024 Direct Common Stock

Transactions reported by Stelios Papadopoulos for Regulus Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.